YC
RGEN icon

Yarbrough Capital’s Repligen RGEN Stock Holding History

Yarbrough Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,448
Closed -$450K – 202
2024
Q1 		$450K Hold
2,448
– – 0.02% 141
2023
Q4 		$440K Hold
2,448
– – 0.02% 148
2023
Q3 		$389K Hold
2,448
– – 0.02% 146
2023
Q2 		$346K Hold
2,448
– – 0.02% 168
2023
Q1 		$412K Hold
2,448
– – 0.03% 141
2022
Q4 		$414K Hold
2,448
– – 0.03% 112
2022
Q3 		$458K Hold
2,448
– – 0.04% 120
2022
Q2 		$398K Buy
+2,448
New +$387K 0.03% 125

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Yarbrough Capital's RGEN Position: Q2 2024 in Review

Yarbrough Capital sold out of Repligen (RGEN) in Q2 2024, closing a stake of 2,448 shares — an estimated $450K sold.

Yarbrough Capital first reported a position in RGEN in Q2 2022 and held it in 8 quarters. The position peaked at $458K in Q3 2022. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Yarbrough Capital reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Yarbrough Capital sold 2,448 Repligen shares in Q2 2024, an estimated $450K.
  • Yarbrough Capital first reported a position in Repligen in Q2 2022 and held it in 8 quarters.
  • Yarbrough Capital's Repligen position peaked at $458K in Q3 2022.
  • 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Yarbrough Capital's 13F filing for Q2 2024, filed 17 Jul 2024.